WHO ICTRP trial
Phase II study of axitinib intensification plus nivolumab compared to nivolumab…
CTIS2024-511397-70-00 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2024-511397-70-00 |
|---|---|
| Public title | Phase II study of axitinib intensification plus nivolumab compared to nivolumab alone after induction with nivolumab plus ipilimumab in mRCC patients without previous complete response (AxIn study) |
| Scientific title | Phase II study of axitinib intensification plus nivolumab compared to nivolumab alone after induction with nivolumab plus ipilimumab in mRCC patients without previous complete response (AxIn study) - AxIn |
| Primary sponsor | Consorzio Oncotech |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): Yes Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No |
| Countries | Italy |
| Conditions | metastatic renal cell carcinoma (mRCC) MedDRA version: 21.1Level: PTClassification code: 10050513Term: Metastatic renal cell carcinoma Class: 100000004864;Therapeutic area: Diseases [C] - Neoplasms [C04];MedDRA version: 21.1Level… |
| Interventions | Product Name: , Product Code:SCP138385, Pharmaceutical Form: , Other descriptive name: , Strength: , Product Name: , Product Code:SCP8265340, Pharmaceutical Form: , Other descriptive name: , Strength: |
| Registration date | Aug 2, 2024 |
| Target size | 118 |
| Secondary IDs | NCT05817903;2022-001150-35 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: